Managing Director, Melbourne

Michael brings over 25 years of experience in M&A advisory, capital raising and corporate law.

Michael structures his transactions to reflect his clients priorities and objectives. He is results focused, brings energy to a project and operates with the highest integrity. Michael prides himself on his many long term client relationships.

Michael has successfully advised corporates (both listed and unlisted), private equity sponsors and high net wealth individuals on numerous domestic and cross border transactions.

Michael�s transaction experience covers mergers and acquisitions, divestments, capital raisings, and strategic reviews.

Prior to joining 333 Capital, Michael was a Director at Merrill Lynch, including two years in the London office and a partner at a mid market focussed corporate advisory firm. Michael commenced his career as a corporate lawyer at Corrs Chambers Westgarth and also Linklaters in London.

\n

\"Completing transactions successfully requires both clear strategy and attention to detail.\"

\n

Significant engagements

  • ConnellGriffin with the majority stake sale to Pemba Capital Partners
  • Infrastructure Advisory Group with the majority stake sale to Quintet Yorkway
  • Carsales' on its exit from Stratton Finance
  • Northland Pensions Group with the majority stake sale to Yorkway Partners
  • Moira Mac's on its sale to Hellers
  • Bureau Veritas on its acquistion of majority stakes in Dairy Technical Services and the McKenzie Group
  • Bapcor on its disposal of its New Zealand footwear business
  • McConnell Seats on its sale to APM
  • Cephalon's acquisition of ChemGenex Pharmaceuticals
  • Sanofi Aventis' acquisition of Zentiva N.V
  • Mayne Pharma's sale to Hospira Inc.
  • CSL's acquisition of Zenyth Therapeutics
  • Sale of ACIRL (Coal Testing) to ALS Limited
  • Sale of Finewrap Packaging to Catalyst Investment Managers
  • Zig Inge Retirement Villages on its 50% sale to Macquarie Capital Alliance Group
  • IPO of Spark Infrastructure
  • Fosters demerger of ALH.